You’re Not the Same After Cancer ‘and That’s OK,’ Says Andrew McMahon

Video

Singer-songwriter Andrew McMahon is not the same person he was before his leukemia diagnosis, and that’s OK, he said.

Lingering thoughts of cancer do not go away, but it is possible to build a hopeful life during survivorship, explained Andrew McMahon, a singer-songwriter and survivor of acute lymphoblastic leukemia (ALL).

While touring with his then-band, Jack ‘s Mannequin in 2005, McMahon was diagnosed with ALL, and underwent chemotherapy, radiation and a stem cell transplant. At first, he told CURE® that he struggled during survivorship, but thanks to support from those around him and the passion he had for his career, he was able to find himself once again.

READ MORE: ‘Beginning of Finding Yourself’ During Cancer Survivorship

“I have so many good memories on the other side of my cancer,” he said. “I think that really is the unfortunate — but also hopeful — reality of what it is to survive trauma or a disease (is) that it just takes time to build up a world for yourself because you're not going to be the same person, and that's OK.”

Transcription

It never goes away. You know, it is … always there and I think at least, you know, luckily for me, I've finally reached a place where my life post-cancer is … more than half of my life almost. … But it is so substantial and has been so rewarding; I have so many good memories on the other side of my cancer, and I think that really is the unfortunate — but also hopeful — reality of what it is to survive trauma or a disease (is) that it just takes time to build up a world for yourself because you're not going to be the same person, and that's OK. … But it took me a long time to make peace with that and say, “OK, well then now I have to make this world a good one to live in, and I'm fortunate that … we have a really nice life, and a lot of good things have happened to me since cancer.” … My daughter, my wife, my marriage, … I live in a beautiful place by a beach that I've always wanted to live in, you know what I mean? And we live simply, but I feedmy family doing something I love and, and all that is after cancer, so it's been a process for sure.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Related Content